Hongbin Li

Person

Madson, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 12,162,888
- Issue date Dec 10, 2024
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...
- Patent number 11,814,386
- Issue date Nov 14, 2023
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,787,803
- Issue date Oct 17, 2023
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...
- Patent number 11,535,618
- Issue date Dec 27, 2022
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,524,966
- Issue date Dec 13, 2022
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,325,917
- Issue date May 10, 2022
- Valo Health, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,292,791
- Issue date Apr 5, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 11,254,674
- Issue date Feb 22, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,995,078
- Issue date May 4, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,913,753
- Issue date Feb 9, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,889,592
- Issue date Jan 12, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 10,870,648
- Issue date Dec 22, 2020
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,800,750
- Issue date Oct 13, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,472,342
- Issue date Nov 12, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,457,655
- Issue date Oct 29, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,450,286
- Issue date Oct 22, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,399,951
- Issue date Sep 3, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-membered heterocyclic amides and related compounds
- Patent number 9,133,204
- Issue date Sep 15, 2015
- H. Lundbeck A/S
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl amide derivatives
- Patent number 8,431,593
- Issue date Apr 30, 2013
- H. Lundbeck A/S
- Alan J. Hutchison
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20240150349
- Publication date May 9, 2024
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20240132499
- Publication date Apr 25, 2024
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20230126252
- Publication date Apr 27, 2023
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZOLE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICIN...
- Publication number 20220213086
- Publication date Jul 7, 2022
- Eternity Bioscience Inc.
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)
- Publication number 20220213089
- Publication date Jul 7, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. SCHILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALKYNE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICI...
- Publication number 20220177446
- Publication date Jun 9, 2022
- Eternity Bioscience Inc.
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20220169647
- Publication date Jun 2, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20220162207
- Publication date May 26, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRAK INHIBITORS, PREPARATION METHOD AND MEDICINAL USES THEREOF
- Publication number 20220144842
- Publication date May 12, 2022
- Eternity Bioscience Inc.
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...
- Publication number 20210355126
- Publication date Nov 18, 2021
- Forma Therapeutics, Inc.
- Alex J. Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210323975
- Publication date Oct 21, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20210214323
- Publication date Jul 15, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING DEUBIQUITINASE USP25 AND USP28
- Publication number 20210179628
- Publication date Jun 17, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210047343
- Publication date Feb 18, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20200347025
- Publication date Nov 5, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200299295
- Publication date Sep 24, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20200216445
- Publication date Jul 9, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20200017458
- Publication date Jan 16, 2020
- FORMA Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20200017525
- Publication date Jan 16, 2020
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200002332
- Publication date Jan 2, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20190359628
- Publication date Nov 28, 2019
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20190241532
- Publication date Aug 8, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20190241533
- Publication date Aug 8, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20180370933
- Publication date Dec 27, 2018
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20180050997
- Publication date Feb 22, 2018
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20160002188
- Publication date Jan 7, 2016
- Forma Therapeutics, Inc.
- KENNETH W. BAIR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-Membered Heterocyclic Amides And Related Compounds
- Publication number 20150005293
- Publication date Jan 1, 2015
- H. LUNDBECK A/S
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-Membered Heterocyclic Amides And Related Compounds
- Publication number 20100292236
- Publication date Nov 18, 2010
- H. Lundbeck A/S
- Hongbin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl Amide Derivatives
- Publication number 20100216763
- Publication date Aug 26, 2010
- H. Lundbeck A/S
- Alan J. Hutchison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heteroaryl CB1 antagonists
- Publication number 20070078135
- Publication date Apr 5, 2007
- Neurogen Corporation
- Jun Yuan
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Carboxamides as ubiquitin-specific protease inhibitors

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30...

Carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Inhibiting CREB binding protein (CBP)

Compounds and compositions for inhibition of FASN

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Inhibiting CREB binding protein (CBP)

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

5-membered heterocyclic amides and related compounds

Heteroaryl amide derivatives

Patents Applicationslast 30 patents

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

AZOLE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICIN...

INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)

ALKYNE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICI...

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

INHIBITING CREB BINDING PROTEIN (CBP)

IRAK INHIBITORS, PREPARATION METHOD AND MEDICINAL USES THEREOF

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30...

CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

INHIBITING DEUBIQUITINASE USP25 AND USP28

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

INHIBITING CREB BINDING PROTEIN (CBP)

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors

INHIBITING CREB BINDING PROTEIN (CBP)

Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

5-Membered Heterocyclic Amides And Related Compounds

5-Membered Heterocyclic Amides And Related Compounds

Heteroaryl Amide Derivatives

Substituted heteroaryl CB1 antagonists